KILITCH DRUGS Share Price

Kilitch Drugs (India) Limited is an India-based pharmaceutical manufacturing company. The Company is mainly engaged in the development and operations of the pharmaceutical business. Its services range from manufacturing to marketing a host of formulations in all dosage forms. The Company offers products in the categories of Parenteral and Nasal Products, Oral, Effervescent, Nutritional Products, Medical Devices, and Cosmetics and Herbal Products. It offers products that help in gastroenterology, anti-inflammatory, anti-malaria, diagnostics, uterine stimulants, veterinary and many more areas in the form of ampoules & vials. Its range of oral formulations includes tablets, capsules, dry syrups and oral powders. It provides a range of cosmetics ranging from oil, lotion, liquid to cream and paste in the skin care, personal care and hair care categories. It offers a medical device, namely, the C-Seal. ROIPAR, ROIVIT, PH-7, C-SEAL, SRO-KIT, 9-VIT, HPURE are their product offerings.As of 25 May 2026, KILITCH DRUGS share price is ₹185.18. The stock opened at ₹188.90, compared to its previous close of ₹182.27. During today's trading session, KILITCH DRUGS share price moved in the range of ₹184.10 to ₹197.00, with an average price of ₹190.55 for the day. Looking at its last 52-week, the stock has touched a low of ₹184.10 and a high of ₹197.00. On the performance front, KILITCH DRUGS share price has increased by 4.80% over the last six months and is down 19.89% on a year-on-year basis.

The market capitalization of KILITCH DRUGS is ₹639 Crs, with a P/E ratio of 21.7 and a dividend yield of 0.00%.